Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Sun Pharma Advanced Share Price
Sun Pharma Advanced Research Company Ltd.
₹235.80
Sun Pharma Advanced Performance
Price Movement
₹212.00
₹239.40
1 Year Performance
₹108.00
₹214.00
Markets Today
Historical Performance
Sun Pharma Advanced Fundamentals
Sun Pharma Advanced Financials
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 1,853.22 | 8.45 | 7.86 | 9.64 | 27.19 |
| Operating Expense | 80.28 | 65.32 | 73.75 | 61.97 | 81.11 |
| Operating Profit | 1,772.94 | -56.87 | -65.89 | -52.33 | -53.92 |
| Depreciation | 2.40 | 2.56 | 2.57 | 2.54 | 2.55 |
| Interest | 11.64 | 8.78 | 7.52 | 6.18 | 4.51 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1,760.70 | -80.57 | -75.97 | -52.03 | -60.98 |
Sun Pharma Advanced Technicals
Sun Pharma Advanced Research Company Ltd. EMA & SMA
₹235.80
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Sun Pharma Advanced Support and Resistance
Resistance
Support
Technical Indicators
Sun Pharma Advanced Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 65.7 | 65.7 | 65.7 | 65.7 | 65.7 | 65.7 |
| FII | 2.2 | 1.4 | 1.5 | 1.8 | 2 | 2 |
| DII | 0.7 | 1.2 | 0.9 | 1 | 0.8 | 0.9 |
| Public | 31.5 | 31.8 | 28.4 | 31.5 | 31.5 | 31.4 |
Sun Pharma Advanced Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 46.93 L | 3.36 Cr | 13.97% |
| Week | 24.35 L | 1.87 Cr | 13.01% |
| 1 Month | 17.52 L | 80.06 L | 21.88% |
| 6 Month | 8.93 L | 47.09 L | 18.96% |
Sun Pharma Advanced SWOT Analysis
Positive Breakout First Resistance ( LTP > R1)
Best results last week in YoY net profit and revenue growth
High DVM Mid and Small Caps (subscription)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Profit making Companies with High ROCE and Low PE
Companies with 10% increase in share price over three months, with rising net profit growth
Undervalued Growth Stocks
Strong Momentum: Price above short, medium and long term moving averages
Jim Slater's Zulu Principle (Discover Growth Stocks)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Affordable Stocks with High ROE and Momentum
Growth Stars: Strongest Annual EPS Performers
Strong QoQ EPS Growth in recent results
Turnaround Companies: Loss to Profit QoQ
Stocks whose current price is 20% higher than week low, and more than previous close
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Stringent DVM Screener
Weekly Screener: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Turnaround companies- loss to profit QoQ
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
Stock with Low PE (PE < = 10)
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
High Volume, High Gain
New 52 Week High
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Insiders bought stocks
Stocks Outperforming their Industry Price Change in the Quarter
Sun Pharma Advanced Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Sun Pharma Advanced Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,681.10 | ₹696 | ₹943.35 | ₹1,160 | ₹4,620 | ₹521.20 |
| % Change | -0.21% | 3.36% | -0.67% | 4.42% | -2.43% | 0.22% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | ₹642.26 | ₹1,598.19 | ₹649.50 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | ₹172.89 | ₹206.20 | ₹115.38 | ₹257.90 | ₹255.19 |
| PE TTM | 56.20 | 45.50 | 75.60 | 46.00 | 41.20 | 32.10 |
| 1 Year Return | 60.19 | 17.5 | 94.75 | 127.32 | -7.99 | -7.96 |
| ROCE | 31.54 | 24.22 | 34.76 | 15.60 | - | 11.40 |
Similar Stocks
BLUEJET
Blue Jet Healthcare Ltd
₹ 483.95
+9.73%
CONCORDBIO
Concord Biotech Ltd.
₹ 1131.20
-1.92%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 735.45
+3.13%
SUPRIYA
Supriya Lifescience Ltd.
₹ 765.65
-1.09%
ALIVUS
Alivus Life Sciences Ltd.
₹ 1059.90
+2.01%
COHANCE
Cohance Lifesciences Ltd.
₹ 435.50
+4.05%
ERIS
Eris Lifesciences Ltd.
₹ 1353.40
+0.71%
SYNGENE
Syngene International Ltd.
₹ 462.45
+0.13%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 759.95
+0.56%
STAR
Strides Pharma Science Ltd.
₹ 1185.00
+2.76%
GRANULES
Granules India Ltd.
₹ 760.40
+1.12%
FDC
FDC Ltd.
₹ 369.00
-1.14%
SHILPAMED
Shilpa Medicare Ltd.
₹ 514.60
+4.97%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 995.10
-1.12%
CAPLIPOINT
Caplin Point Laboratories Ltd.
₹ 2082.00
+2.66%
MARKSANS
Marksans Pharma Ltd.
₹ 220.55
+4.10%
SANOFI
Sanofi India Ltd.
₹ 3179.00
+0.50%
PGHL
Procter & Gamble Health Ltd.
₹ 5741.00
+3.39%
JSLL
Jeena Sikho Lifecare Ltd.
₹ 635.00
-2.27%
FAQ's on SPARC
What is the current share price of Sun Pharma Advanced Research Company Ltd.?
What is the Market Capitalization of Sun Pharma Advanced Research Company Ltd.?
What are the PE and PB ratios for Sun Pharma Advanced Research Company Ltd.?
What is the 52-Week High and Low for Sun Pharma Advanced Research Company Ltd.?
Who are the major shareholders of Sun Pharma Advanced Research Company Ltd.?
- Promoter
- Public
- FII
- Mutual Funds
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Sun Pharma Advanced Research Company Ltd. in the Pharmaceuticals & Biotechnology sector?
By signing up I certify terms, conditions & privacy policy